Top

Published in:

01-08-2009 | Review

Imatinib use during pregnancy and breast feeding: a case report and review of the literature

Authors: Ridvan Ali, Fahir Ozkalemkas, Yalcin Kimya, Nilgun Koksal, Vildan Ozkocaman, Tuna Gulten, Hakan Yorulmaz, Ahmet Tunali

Published in: Archives of Gynecology and Obstetrics | Issue 2/2009

Abstract

Introduction

The development of imatinib as a therapeutic agent targeting BCR-ABL has increased the treatment options for chronic myeloid leukemia (CML) by significantly impacting outcomes, and imatinib is recommended by treatment guidelines as the first-line therapy. However, treatment of maternal CML with imatinib during gestation is not recommended because of the potential risk to the fetus.

Materials and methods

We describe the clinical presentation, course and outcome of one pregnant patient with CML who was treated with imatinib. We review all pregnancies associated with imatinib documented in the literature.

Case presentation

A 27-year-old pregnant patient was diagnosed to have Philadelphia chromosome positive chronic phase CML in August 2007. Imatinib was administered (400 mg/day) between the 21st and 39th weeks of gestation. The patient tolerated the drug well and achieved complete hematological and cytogenetic remission. There were no imatinib-related maternal complications during the pregnancy. Fetal growth remained normal as well as amniotic fluid volume estimation. Labor was induced at the 39th gestational week, resulting in the uneventful vaginal delivery of a healthy male infant without any congenital anomaly. Umbilical cord blood and infant peripheral blood were collected at delivery. No postnatal complications occurred; however, imatinib was present in the umbilical cord blood (338 ng/mL) and in the infant’s peripheral blood (478 ng/mL). Breast milk was collected on different postpartum days, and concentrations of imatinib were detected. At 10 months of age, the baby had normal growth and development.

Conclusions

In light of reported cases and our experience, treatment of CML during the second and third trimesters of gestation and breast feeding seems to be safe, but the data are still limited and the effects of chronic exposure of infants to imatinib are not known. We think that each case should be examined and considered independently, and decisions should be individualized.

Kyriakides S (2008) Psychosocial issues in young women facing cancer and pregnancy: the role of patient advocacy. Recent Results Cancer Res 178:247–252. doi:10.1007/978-3-540-71274-9_21 PubMedCrossRef

Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozan U, Kimya Y, Koksal N, Gulten T, Yakut T, Tunali A (2005) Pregnancy under treatment of imatinib and successful labor in a patient with chronic myelogenous leukemia (CML). Outcome of discontinuation of imatinib therapy after achieving a molecular remission. Leuk Res 29:971–973. doi:10.1016/j.leukres.2005.01.009 PubMedCrossRef

Ali R, Ozkalemkas F, Ozkocaman V, Ozcelik T, Ozan U, Kimya Y, Tunali A (2004) Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature. Jpn J Clin Oncol 34:215–217. doi:10.1093/jjco/hyh038 PubMedCrossRef

Hensley ML, Ford JM (2003) Imatinib treatment: specific issues related to safety, fertility, and pregnancy. Semin Hematol 40(2(Suppl 2)):21–25. doi:10.1016/S0037-1963(03)70016-X PubMed

Goldman JM (2007) How I treat chronic myeloid leukemia in the imatinib era. Blood 110:2828–2837. doi:10.1182/blood-2007-04-038943 PubMedCrossRef

Henkes M, van der Kuip H, Aulitzky WE (2008) Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark). Ther Clin Risk Manage 4:163–187

Ault P, Kantarjian H, O’Brien S, Faderl S, Beran M, Rios MB, Koller C, Giles F, Keating M, Talpaz M, Cortes J (2006) Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 24:1204–1208. doi:10.1200/JCO.2005.04.6557 PubMedCrossRef

Ali R, Ozkalemkas F, Ozcelik T, Ozkocaman V, Ozkan A (2006) Imatinib and pregnancy. J Clin Oncol 24:3812–3813. doi:10.1200/JCO.2006.06.9310 PubMedCrossRef

Klaasen R, de Jong P, Wijermans PW (2007) Successful management of chronic myeloid leukaemia with leucapheresis during a twin pregnancy. Neth J Med 65:147–149PubMed

10.

Atallah E, Kantarjian H, Cortes J (2007) Emerging safety issues with imatinib and other Abl tyrosine kinase inhibitors. Clin Lymphoma Myeloma 7(Suppl 3):S105–S112. doi:10.3816/CLM.2007.s.010 PubMedCrossRef

11.

Heartin E, Walkinshaw S, Clark RE (2004) Successful outcome of pregnancy in chronic myeloid leukaemia treated with imatinib. Leuk Lymphoma 45:1307–1308. doi:10.1080/10428190310001645195 PubMedCrossRef

12.

Sotiropoulos D, Adamidou D, Athanasiadou A, Goulis DG, Fassas A, Anagnostopoulos A (2004) Two pregnancies resulting in a healthy newborn in a CML patient treated with imatinib. Blood 104 (Abstract 4694)

13.

Fogliatto L, Brum C, Zago A, Faltoe T, Rodrigues F, Falhauber G, Leugeur D, Silla L (2005) Pregnancy during treatment with imatinib: a case report. Blood 106 (Abstract 4851)

14.

AlKindi S, Dennison D, Pathare A (2005) Imatinib in pregnancy. Eur J Haematol 74:535–537. doi:10.1111/j.1600-0609.2005.00420.x PubMedCrossRef

15.

Prabhash K, Sastry PS, Biswas G, Bakshi A, Prasad N, Menon H, Parikh PM (2005) Pregnancy outcome of two patients treated with imatinib. Ann Oncol 16:1983–1984. doi:10.1093/annonc/mdi398 PubMedCrossRef

16.

Choudhary DR, Mishra P, Kumar R, Mahapatra M, Choudhry VP (2006) Pregnancy on imatinib: fatal outcome with meningocele. Ann Oncol 17:178–179. doi:10.1093/annonc/mdj065 PubMedCrossRef

17.

Suppiah R, Kalaycio M (2006) Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester. Leuk Lymphoma 47:1149–1150. doi:10.1080/10428190500399029 PubMedCrossRef

18.

Koh LP, Kanagalingam D (2006) Pregnancies in patients with chronic myeloid leukemia in the era of imatinib. Int J Hematol 84:459–462. doi:10.1532/IJH97.A20610 PubMedCrossRef

19.

Russell MA, Carpenter MW, Akhtar MS, Lagattuta TF, Egorin MJ (2007) Imatinib mesylate and metabolite concentrations in maternal blood, umbilical cord blood, placenta and breast milk. J Perinatol 27:241–243. doi:10.1038/sj.jp.7211665 PubMedCrossRef

20.

Garderet L, Santacruz R, Barbu V, van den Akker J, Carbonne B, Gorin NC (2007) Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib. Haematologica 92:e9–e10. doi:10.3324/haematol.10935 PubMedCrossRef

21.

Yilmaz M, Demirhan O, Kuçukosmanoglu E, Pehlivan M, Okan V, Balat O, Pehlivan S (2007) Pregnancy in patients with chronic myeloid leukemia treated with imatinib. Leuk Lymphoma 48:2454–2456. doi:10.1080/10428190701658751 PubMedCrossRef

22.

Buyukbayrak EE, Ergen B, Karsidag YK, Kars B, Turan C, Argon D (2008) Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report. Arch Gynecol Obstet 278:161–163. doi:10.1007/s00404-007-0547-6 PubMedCrossRef

23.

Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF (2008) The effects of imatinib on pregnancy outcome. Blood 111:5505–5508. doi:10.1182/blood-2007-10-114900 PubMedCrossRef

24.

Meera V, Jijina F, Shrikande M, Madkaikar M, Ghosh K (2008) Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy. Leuk Res 32:1620–1622. doi:10.1016/j.leukres.2008.03.007 PubMedCrossRef

25.

Dolai TK, Bhargava R, Mahapatra M, Mishra P, Seth T, Pati HP, Saxena R (2008) Is imatinib safe during pregnancy? Leuk Res (Epub ahead of print). doi:10.1016/j.leukres.2008.08.002

26.

Skoumalova I, Vondrakova J, Rohon P, Rozmanova S, Jarosova M, Indrak K, Prochazka M, Santava A, Faber E (2008) Successful childbirth in a patient with chronic myelogenous leukemia treated with imatinib mesylate during early pregnancy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152:121–123PubMed

27.

Sorà F, De Matteis S, Bajer J, D’alò F, Leone G, Sica S (2008) Persistence of molecular remission throughout pregnancy in CML after imatinib. Leuk Res (Epub ahead of print). doi:10.1016/j.leukres.2008.09.12

28.

Gambacorti-Passerini CB, Tornaghi L, Marangon E, Franceschino A, Pogliani EM, D’Incalci M, Zucchetti M (2007) Imatinib concentrations in human milk. Blood 109:1790PubMed

29.

Shehata HA, Nelson-Piercy C (2000) Drugs to avoid in pregnancy. Curr Obstet Gynaecol 10:44–52. doi:10.1054/cuog.2000.0104 CrossRef

30.

Pentheroudakis G, Pavlidis N (2006) Cancer and pregnancy: poena magna, not anymore. Eur J Cancer 42:126–140. doi:10.1016/j.ejca.2005.10.014 PubMedCrossRef

31.

Cardonick E, Iacobucci A (2004) Use of chemotherapy during human pregnancy. Lancet Oncol 5:283–291. doi:10.1016/S1470-2045(04)01466-4 PubMedCrossRef

32.

Fey MF, Surbek D (2008) Leukaemia and pregnancy. Recent Results Cancer Res 178:97–110. doi:10.1007/978-3-540-71274-9_10 PubMedCrossRef

Title: Imatinib use during pregnancy and breast feeding: a case report and review of the literature
Authors: Ridvan Ali
Fahir Ozkalemkas
Yalcin Kimya
Nilgun Koksal
Vildan Ozkocaman
Tuna Gulten
Hakan Yorulmaz
Ahmet Tunali
Publication date: 01-08-2009
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 2/2009
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-008-0861-7

At a glance: The STEP trials

Springer Medicine

Imatinib use during pregnancy and breast feeding: a case report and review of the literature

Abstract

Introduction

Materials and methods

Case presentation

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Materials and methods

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 2/2009

Prenatal management of an allantoic cyst with patent urachus

Galactography acquired with digital mammography in patients with nipple discharge: a retrospective analysis

The effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome

Accessory breast tissue presenting as a vulvar mass in an adolescent girl

Peritoneal tuberculosis with elevated serum Ca-125 level mimicking advanced stage ovarian cancer: a case report

An extraordinary cause of vertebral fracture in pregnant woman: brucellosis